Elekta AB is a global medical technology company focused on developing and manufacturing advanced clinical solutions for oncology and neurosurgery. The company's core business model revolves around the sale of capital equipment, software, and recurring service contracts. Elekta's product portfolio includes linear accelerators (Linacs) for external beam radiation therapy, the Leksell Gamma Knife for stereotactic radiosurgery, brachytherapy solutions for internal radiation, and the Elekta Unity MR-Linac, which integrates magnetic resonance imaging with radiation delivery. Additionally, the company provides oncology informatics software, such as the MOSAIQ oncology information system and Monaco treatment planning software, which help clinics manage patient workflows and treatment plans. Revenue is generated through two primary streams: Solutions (capital equipment and software sales) and Services (maintenance, support, and training), which provide a stable recurring revenue base. Geographically, Elekta's sales are well-diversified, with significant contributions from North and South America, Europe, the Middle East, and Africa (EMEA), and the Asia-Pacific region. The company holds a strong competitive position in the global radiation oncology market, operating in a highly consolidated industry alongside major competitors like Varian Medical Systems.
